MURO 128- sodium chloride solution 
Bausch & Lomb Incorporated

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Muro 128

Drug Facts

Active ingredient

Sodium chloride 5%

Purpose

Hypertonicity agent

Uses

temporary relief of corneal edema

Warnings

For external use only

Do not use

except under the advice and supervision of a doctor
if solution changes color or becomes cloudy

When using this product  

it may cause temporary burning and irritation
to avoid contamination, do not touch tip of container to any surface
replace cap after use

Stop use and ask a doctor if

condition worsens or persists for more than 72 hours
you experience eye pain, changes in vision, continued redness or irritation of the eye

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

 
Instill 1 or 2 drops in the affected eye(s) every 3 or 4 hours, or as directed by a doctor.

Other information

store upright at 15–25 °C (59–77 °F)
keep tightly closed
serious side effects associated with use of the product may be reported to the phone number provided below

 

Inactive ingredients

boric acid, hypromellose, methylparaben, propylene glycol, propylparaben, purified water, sodium borate. Hydrochloric acid and/or sodium hydroxide may be added to adjust pH.

Questions or comments?

[telephone icon] Call1-800-553-5340

Muro 128 is a trademark of Bausch & Lomb Incorporated or its affiliates.

© 2022 Bausch & Lomb Incorporated or its affiliates

Marketed by:

Bausch & Lomb Americas Inc.

Bridgewater, NJ 08807 USA

9756601

AB15611

Package/Label Principal Display Panel – Muro 128 15 mL

carton5%

BAUSCH + LOMB

NDC 24208-277-15

Muro 128®

sodium chloride hypertonicity

ophthalmic solution, 5%

SOLUTION

5%

Temporary Relief

of Corneal Edema

STERILE

1/2 FL OZ (15 mL)

MURO 128 
sodium chloride solution
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:24208-277
Route of AdministrationOPHTHALMIC
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X) (SODIUM CATION - UNII:LYR4M0NH37) SODIUM CHLORIDE50 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
BORIC ACID (UNII: R57ZHV85D4)  
HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
WATER (UNII: 059QF0KO0R)  
SODIUM BORATE (UNII: 91MBZ8H3QO)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
PROPYLPARABEN (UNII: Z8IX2SC1OH)  
HYDROCHLORIC ACID (UNII: QTT17582CB)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:24208-277-151 in 1 CARTON01/01/2011
115 mL in 1 BOTTLE; Type 0: Not a Combination Product
2NDC:24208-277-301 in 1 CARTON01/01/201101/01/2020
230 mL in 1 BOTTLE; Type 0: Not a Combination Product
3NDC:24208-277-591 in 1 CARTON01/01/2011
32 mL in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart34901/01/2011
Labeler - Bausch & Lomb Incorporated (196603781)
Establishment
NameAddressID/FEIBusiness Operations
Bausch & Lomb Incorporated079587625MANUFACTURE(24208-277)

Revised: 5/2022
Document Id: c9211ab1-d0af-4298-bfc1-9840cc131903
Set id: 454f337e-d897-46de-ab05-1c543a33061c
Version: 7
Effective Time: 20220525
 
Bausch & Lomb Incorporated